Continuous versus intermittent extended djuvant letrozole for breast cancer: final results of randomized phase III SOLE Study of Letrozole Extension) and SOLE Estrogen Substudy
G. Jerusalem, S. Farah, A. Courtois, J. Chirgwin, S. Aebi, P. Karlsson, P. Neven, E. Hitre, M. P. Graas, E. Simoncini, E. Abdi, C. Kamby, A. Thompson, S. Loibl, J. Gavilá, K. Kuroi, C. Marth, B. Müller, S. O’Reilly, A. Gombos, T. Ruhstaller, H. J. Burstein, M. Rabaglio, B. Ruepp, K. Ribi, G. Viale, R. D. Gelber, A. S. Coates, S. Loi, A. Goldhirsch, M. M. Regan & M. Colleoni, on behalf of the SOLE Investigators
Manuscrito
Annals of Oncology
2021
SOLE
